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ABSTRACT
Burkholderia thailandensis has three acyl-homoserine lactone (AHL) LuxR-LuxI quorum-sensing circuits and two orphan LuxR
homologs. Orphans are LuxR-type transcription factors that do not have cognate LuxI-type AHL synthases. One of the orphans,
MalR, is genetically linked to the mal gene cluster, which encodes enzymes required for production of the cytotoxic polyketide
malleilactone. Under normal laboratory conditions the mal gene cluster is silent; however, antibiotics like trimethoprim induce
mal transcription. We show that trimethoprim-dependent induction of the mal genes requires MalR. MalR has all of the con-
served amino acid residues characteristic of AHL-responsive LuxR homologs, but in B. thailandensis, MalR activation of mallei-
lactone synthesis genes is not responsive to AHLs. MalR can activate transcription from the mal promoter in E. coli without ad-
dition of AHLs or trimethoprim. Expression of malR in B. thailandensis is induced by trimethoprim. Our data indicate that
MalR binds to a lux box-like element in the mal promoter and activates transcription of the mal genes in an AHL-independent
manner. Antibiotics like trimethoprim appear to activate mal gene expression indirectly by somehow activating malR expres-
sion. MalR activation of the mal genes represents an example of a LuxR homolog that is not a receptor for an AHL quorum-sens-
ing signal. Our evidence is consistent with the idea that mal gene activation depends solely on sufficient transcription of the
malR gene.
IMPORTANCE
LuxR proteins are transcription factors that are typically activated by acyl-homoserine lactone (AHL) signals. We demonstrate
that a conserved LuxR family protein, MalR, activates genes independently of AHLs. MalR is required for transcription of genes
coding for synthesis of the cytotoxic polyketide malleilactone. These genes are not expressed when cells are grown under normal
laboratory conditions. In laboratory culture, MalR induction of malleilactone requires certain antibiotics, such as trimethoprim,
which increase malR expression by an unknown mechanism. At sufficient levels of malR expression, MalR functions indepen-
dently of any external signal. Our findings show that MalR is an activator of the silent malleilactone biosynthesis genes and that
MalR functions independently of AHLs.
Acyl-homoserine lactone (AHL) quorum-sensing systems arewidespread among the Proteobacteria. AHLs are generated by
members of the LuxI family of AHL synthases. Members of the
LuxR protein family serve as cognate AHL-dependent transcrip-
tion factors. Often, the genes targeted by LuxR family members
have an 18- to 20-base inverted repeat in their promoter regions
that shows conservation across species. These repeat elements are
called lux box-like sequences and serve as binding sites for the
transcription factors. Sequence identity in pairwise comparisons
of LuxR polypeptides is rather limited (18 to 35%), but there is a
conserved N-terminal AHL binding region and a conserved C-ter-
minal DNA binding region where sequence identity is higher and
where there are highly conserved residues (see references 1 and 2
for reviews).
Burkholderia thailandensis has three pairs of luxI-luxR-type
genes called btaI1-btaR1, btaI2-btaR2, and btaI3-btaR3. Each of
the luxR homologs is linked to its cognate luxI homolog, as is the
case for luxI-luxR-type gene pairs in many other bacteria. This
species also has two additional luxR homologs, btaR4 (now called
malR [see below]) and btaR5 (3). LuxR family members like MalR
and BtaR5 are called orphans (4) or solos (5), because the genes
encoding these polypeptides are not associated with a luxI ho-
molog. Relatively few orphans have been characterized. Some or-
phans, like Pseudomonas aeruginosa QscR or Salmonella enterica
serovar Typhimurium SdiA, show complete conservation of all of
the invariant residues in the signal binding region of AHL-respon-
sive LuxR family members and in fact respond to AHLs that are
self-produced (6) or exogenously supplied (7, 8). Other LuxR
family members, like Xanthomonas oryzae OryR and Photorhab-
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dus asymbiotica PauR, show conservation in the AHL binding re-
gion but vary with respect to at least one of the conserved residues.
OryR and PauR do not respond to AHLs. Rather, they respond to
host-derived factors or an endogenously produced secondary me-
tabolite, respectively (9, 10).
We are interested in the B. thailandensis MalR protein for sev-
eral reasons. First, it shows complete identity in all of the residues
conserved among AHL-responsive LuxR family members. Sec-
ond, it is adjacent to and divergently transcribed from the mal
gene cluster, which is required for the production of the B. thai-
landensis cytotoxic polyketide malleilactone. The genes for MalR
and malleilactone biosynthesis are silent when B. thailandensis is
grown in standard laboratory media but expressed in cells grown
with certain antibiotics, such as trimethoprim (11). Third, malR
and the mal genes are required for Caenorhabditis elegans infec-
tions (12). There is a lux box-like sequence in the promoter region
of the mal operon. One might imagine that MalR is an AHL-
responsive activator of the mal operon. However, the mal operon
is silent under laboratory conditions where AHLs are produced.
Perhaps MalR binds to a signal other than an AHL. This would be
unusual, but perhaps not unique (13), for a LuxR family member
showing complete identity with the conserved residues in the AHL
binding and DNA binding regions. We seek to understand how
the mal operon is regulated because its product, malleilactone,
appears to be a virulence factor and because it may be regulated by
MalR in an unusual manner.
Here, we show MalR is required for trimethoprim activation of
the malleilactone genes and mal gene transcription is stimulated
by several, but not all, antibiotics. Activation of the mal genes does
not involve any of the AHLs tested in B. thailandensis or in recom-
binant Escherichia coli. We also show that induction is not the
consequence of a general antibiotic stress response, nor does it
involve a direct interaction of MalR with a malleilactone-inducing
antibiotic. Our results are consistent with a model whereby certain
antibiotics activate expression of the silent malR gene and the
malR gene product in turn activates transcription of genes for
malleilactone synthesis.
MATERIALS AND METHODS
Bacterial strains, culture conditions, and reagents. We used B. thailan-
densis strain E264 (14) and E. coli strain DH5 or MG4 for genetic ma-
nipulations and recombinant DNA expression, respectively (see Table S1
in the supplemental material). Our B. thailandensis malA-lacZ chromo-
somal insertion mutant (BT01447) was from a sequence-defined trans-
poson mutant library (15). This mutant has a transposon insertion in the
malA coding sequence after bp 5704 (out of 8,379) relative to the pre-
dicted malA translational start site. The other strains are listed in Table S1
in the supplemental material.
All E. coli growth was in Luria-Bertani (LB) broth at 37°C with shak-
ing, and B. thailandensis was grown in morpholinepropanesulfonic acid
(MOPS)-buffered LB broth (LB-MOPS) at 30°C with shaking. When ap-
propriate, the following antibiotics were used (per milliliter): 100 g tri-
methoprim (E. coli and B. thailandensis) and 15 g gentamicin and 100 g
ampicillin (E. coli). We added IPTG (isopropyl--D-thiogalactopyrano-
side) as indicated.
We measured -galactosidase activity with a Tropix Galacto-Light
Plus chemiluminescence kit according to the manufacturer’s protocol
(Applied Biosystems, Foster City, CA). -Galactosidase activity in B. thai-
landensis is reported as light units relative to the optical density at 600 nm
(OD600). Genomic DNA, PCR and DNA fragments, and plasmid DNA
were purified by using a DNeasy blood and tissue kit, PCR, plasmid pu-
rification kit, or gel extraction kit (Qiagen) according to the manufactur-
er’s protocol.
Genetic manipulations. We used standard procedures for DNA ma-
nipulations (16). To assess malA-lacZ expression in a malR-null back-
ground, an unmarked, in-frame malR deletion was introduced into the
malA-lacZ reporter strain BT01447 by using the deletion construct
pJRC115 btaR4, which we now call malR, and methods described previ-
ously (17). To assess malA-lacZ activity in an AHL synthase-deficient
strain, we prepared genomic DNA from BT01447 and introduced it into
the btaI1 btaI2 btaI3 triple mutant JBT112 (17) by using natural transfor-
mation as described previously (18). The pUC18-mini-Tn7T derivatives
were introduced into B. thailandensis strains with the helper plasmid
pTNS2 by electroporation, as previously described (19). We used PCR to
verify insertion into the attn7 site near glmS1 as previously described (15).
Where indicated, we removed the trimethoprim resistance marker dhfrIIb
from pUC18-mini-Tn7T derivatives by using plasmid pFLPe2, as de-
scribed previously (20).
The plasmids are listed in Table S1 in the supplemental material. To
generate pJN105.malR for recombinant malR expression in E. coli, malR
was amplified from genomic DNA isolated from B. thailandensis E264 by
using primers that incorporated restriction sites (NheI and SpeI) into the
product. The amplicon was cut with NheI and SpeI and ligated into NheI-
SpeI-digested pJN105 to make pJN105.malR. To generate the E. coli
malA-lacZ expression vector pQF50.malA, the region upstream of malA
extending from positions 1 to 500 with respect to the translational
start site was amplified by PCR by using primers that incorporated restric-
tion sites (NcoI and HindIII) into the product. The amplicon was digested
with NcoI and HindIII and ligated to NcoI-HindIII-digested pQF50 to
make pQF50.PmalA. To make the malA-lacZ expression vector with mu-
tations in the putative lux box, we used a synthetic DNA fragment (IDT
gBlock) identical to the PCR amplicon used to make pQF50.PmalA, ex-
cept with the base substitutions T4C and G5A in the putative lux box. This
gBlock was digested with NcoI and HindIII and ligated to NcoI-HindIII-
digested pQF50 to make pQF50.mutPmalA. To make the plac-malR ex-
pression cassette, we first constructed the IPTG-inducible expression vec-
tor pUC18-mini-Tn7T-LAC-Tp by digesting the fragment containing the
lac promoter and lacI repressor gene from pUC18-mini-Tn7T-LAC with
NsiI and SpeI and ligating it to NsiI-SpeI-digested pUC18-mini-Tn7T-Tp
(21). We then cloned malR into this vector by cutting malR from
pJN105.malR using the NheI and SpeI sites and ligating it to SpeI-cut
pUC18-mini-Tn7T-LAC-Tp. We verified the orientation of malR with
respect to the lac promoter in the resulting construct, pUC18-mini-Tn7T-
LAC-Tp.malR, by PCR.
Transcription reporter assays. To assess MalR activation of malA
expression in recombinant E. coli, we used E. coli MG4 with arabinose-
inducible malR (pJN105.malR) and either pQF50.PmalA with lacZ fused
to the wild-type malA promoter or pQF50.mutPmalA with lacZ fused to
the T4C and G5A mutant malA promoter. Overnight cultures were used
as starters by diluting them to an OD600 of 0.05. When experimental
cultures reached an OD600 of 0.5, L-arabinose was added at the concen-
trations indicated to induce MalR expression. These cultures were added
to sterile 16-mm test tubes or test tubes containing dried AHLs, as indi-
cated. The volume of culture in each tube was 0.5 ml. After 2 h at 37°C with
shaking, -galactosidase activity was measured as described above.
To assess MalR activation of malA in B. thailandensis, we used a B.
thailandensis malA-lacZ reporter strain (BT01447) (15). Logarithmic-
phase cultures were diluted to an OD600 of 0.05 in growth medium sup-
plemented with antibiotics or IPTG at the concentrations indicated.
When used, AHLs were added to the culture tube and dried prior to
adding inoculated LB broth. The final AHL concentrations were 5 M.
After 24 h at 30°C with shaking, -galactosidase activity was measured as
described above.
Purification of malleilactone. Malleilactone was purified from B.
thailandensis as follows. A stationary-phase culture of B. thailandensis
E264 was used as the inoculum for 8 640-ml cultures in 4-liter Erlenmeyer
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flasks. The growth medium was LB-MOPS plus 9 g/ml trimethoprim.
Cells were inoculated to an OD600 of 0.05. After 32 h at 30°C with shaking
(200 rpm), the cultures were extracted with 1 volume of ethyl acetate, and
the extract was dried over Na2SO4 and evaporated completely in a vac-
uum. The remaining residue was resolved through a Kupchan liquid ex-
traction scheme. Briefly, the dried extract was dissolved in 200 ml of meth-
anol (MeOH)-H2O (9:1) and extracted four times with 200 ml hexanes.
The remaining methanolic extract was diluted in 800 ml of MeOH-H2O
(6:4), which was extracted four times with an equal volume of CH2Cl2.
High-performance liquid chromatography–mass spectrometry (HPLC-
MS) analysis of the three resulting fractions (MeOH-H2O, CH2Cl2, and
hexanes) showed that malleilactone was in the CH2Cl2 fraction. This frac-
tion was dried, suspended in a small volume (2 to 3 ml) of CH2Cl2, and
resolved on a silica gel column (16 g; diameter, 1.25 cm; length, 20 cm).
The column was equilibrated in CH2Cl2, loaded with the malleilactone-
containing mixture, and eluted with 3 column volumes (CV) of CH2Cl2,
followed by 3 CV (each) of 2.5%, 5%, 7.5%, and 10% MeOH in CH2Cl2.
Fractions containing malleilactone, as judged by thin-layer chromatogra-
phy (TLC) with 5% MeOH in CH2Cl2 as a solvent, were pooled; the
pooled fractions consisted of a number of malleilactone analogs. Pure
malleilactone A was obtained by a final HPLC step consisting of a prepar-
ative Eclipse XCB-C8 column (Agilent; 7 m; 21.2 by 250 mm) operating
at 12 ml/min with an elution program that contained an isocratic step (6
min; 28% acetonitrile [MeCN] in H2O) followed by a gradient from 28 to
100% MeCN over 36 min. Both MeCN and H2O contained 0.1%
NH4OH, which helped stabilize the malleilactone. This procedure yielded
4 mg of pure malleilactone, which was verified by UV-visible (max  370
nm), 1H nuclear magnetic resonance (NMR), and high-resolution elec-
trospray ionization (ESI)-MS ([MH] observed, 307.1907; [MH]
calculated, 307.1909).
RESULTS
MalR is required for trimethoprim induction of mal biosynthe-
sis genes. MalR is a LuxR orphan with all of the LuxR family
conserved amino acids and 35% amino acid sequence identity to
the P. aeruginosa AHL-responsive orphan QscR. MalR is geneti-
cally linked to a 13-gene cluster, the malleilactone (mal)-biosyn-
thetic genes. The mal genes are transcriptionally activated by tri-
methoprim (11). To address the question of whether MalR is
required for trimethoprim to induce expression of the mal genes,
we used a B. thailandensis strain with a chromosomal lacZ fusion
to malA, the first gene in the mal cluster (15). We compared malA-
lacZ activation in a malR mutant to that in wild-type malR. The
lacZ reporter was activated by trimethoprim in the wild type, as
previously reported (11), but not in the malR mutant (Fig. 1).
These results show that MalR is required for trimethoprim activa-
tion of the mal biosynthesis genes.
Influence of antibiotics on mal gene expression and the B.
thailandensis growth rate. Trimethoprim is a dihydrofolate re-
ductase inhibitor. In addition to trimethoprim, several other an-
tibiotics activate the mal operon. They include fluoroquinolone
DNA gyrase inhibitors and the cell wall biosynthesis inhibitors
piperacillin, ceftazidime, and cefotaxime (11). The fact that these
antibiotics are structurally distinct and target different activities
suggests that they might not interact with MalR directly. An alter-
native explanation is that they affect the growth rate of B. thailan-
densis at the sublethal concentrations tested, and this might cor-
relate with activation of the mal genes. We first tested the influence
of trimethoprim, the strongest mal gene inducer (11), on growth
and mal gene induction by using our B. thailandensis malA-lacZ
reporter. At concentrations that induced mal expression, trim-
ethoprim also inhibited bacterial growth (Table 1 and Fig. 2), and
in fact, the level of mal gene expression was inversely correlated
with growth over a range of trimethoprim concentrations (Fig. 2).
We also tested other antibiotics at sub-MIC but growth-slowing
concentrations. Not all of the antibiotics we tested served to acti-
vate malA-lacZ. Kanamycin, for example, did not activate lacZ
expression, but it did inhibit growth (Table 1 and Fig. 2). Thus,
slow growth is not sufficient for activation of the mal genes, but it
may be necessary.
Our malA-lacZ reporter disrupts malA, which is a predicted
polyketide synthase thought to be critical for malleilactone synthesis
(12). Thus, malleilactone itself is likely not required for trimethoprim
and other antibiotics to activate the mal genes. Nevertheless, mallei-
lactone might influence mal gene expression. To address this possi-
bility, we purified malleilactone from cultures of trimethoprim-
treated B. thailandensis cells, where it was estimated to be at a
concentration of 0.8 g/ml (see Materials and Methods). At this con-
centration, our purified malleilactone had a minimal effect on growth
or mal gene expression in the B. thailandensis reporter strain (Fig. 2).
However, at a higher concentration (15 g/ml), malleilactone re-
duced growth by 70 to 80% and showed potency as a malA activator
comparable to that of trimethoprim (Fig. 2).
Transcription from the malA promoter in recombinant E.
















FIG 1 Trimethoprim-dependent expression of malA requires MalR. Shown is
growth-adjusted activity of a malA-lacZ chromosomal reporter in the malR mu-
tant (TT04) (diamonds) or its isogenic parent (BT01447) (circles) grown with
trimethoprim (solid symbols) or without trimethoprim (open symbols). The data
are the means 	 ranges from the results of two independent experiments.
TABLE 1 Abilities of antibiotics to activate malA-lacZ in B. thailandensis




Trimethoprim (15)c THF pathway inhibitord 9.7 (0.4)
Kanamycin (115) Ribosomal inhibitor 0.5 (0.1)
Zeocin (1,200) DNA intercalator 1.5 (0)
Mitomycin C (10) DNA cross-linker 4.3 (0.1)
Sulfamethoxazole (3,000) THF pathway inhibitor 10 (0.7)
Malleilactone (15) Unknown 12.3 (1.5)
a The concentration of antibiotic used is indicated in parentheses, and in each case, the
concentration resulted in a 70 to 80% reduction in the growth yield, as determined by
the OD600 taken at the time of -galactosidase measurement.
b Growth-adjusted -galactosidase activity relative to that of the untreated control. The
-galactosidase activity and OD600 were determined after 24 h. The values are the
means of the results of two independent experiments, with the range indicated in
parentheses.
c Trimethoprim was previously shown to activate malA-lacZ (11).
d THF pathway, tetrahydrofolate reductase pathway.
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neered a plasmid with a 500-bp fragment containing the pre-
sumed malA promoter fused to a promoterless lacZ (from po-
sitions 1 to 500 with respect to the malA translation start
codon) and a plasmid with an arabinose-inducible malR. In E.
coli, lacZ expression was dependent on the presence of both plas-
mids and on arabinose (Fig. 3A).
The lux box-like sequence is centered 63.5 bp upstream of the
malA translational start site (Fig. 3B and C). We tested the hypoth-
esis that MalR requires this lux box-like sequence to activate malA
by introducing the base substitutions T4C and G5A (Fig. 3B),
which are critical for transcription factor binding in LuxR-LuxI-
type systems (22). In E. coli containing this construct, the basal
level of lacZ expression was similar to that in E. coli containing the
full-length malA-lacZ fusion; however, the T4C and G5A substi-
tutions abolished MalR-dependent activation of malA-lacZ (Fig.
3A). Our results are consistent with the idea that MalR binds to the
lux box-like element upstream of malA and that this binding leads
to transcriptional activation of malA. Activation of reporter tran-
scription in E. coli did not require AHLs or antibiotics.
MalR-dependent activation of the mal genes is not influ-
enced by AHLs. Although activation of the malA-lacZ reporter in
E. coli does not require an AHL, it might nevertheless be influ-
enced by AHLs either positively or negatively. Thus, we measured
lacZ expression in our E. coli reporter containing both the malA-
lacZ expression vector and the arabinose-dependent malR expres-
sion vector as follows. We grew the E. coli reporter strain in the
presence of arabinose at a concentration that elicits maximal or
half-maximal MalR-dependent malA-lacZ activation (0.4 or
0.004% arabinose, respectively) plus the following AHLs (5 M
each): octanoyl-homoserine lactone (HSL), 3-hydroxy-octanoyl-
HSL, and 3-hydroxy-decanoyl-HSL (the B. thailandensis AHLs);
butyryl-HSL, hexanoyl-HSL, decanoyl-HSL, dodecanoyl-HSL,
tetradecanoyl-HSL, and 3-hydroxy-hexanoyl-HSL (C4-, C6-,
C10-, C12-, C14-, and 3OHC6-HSL); and p-coumaroyl-HSL. Addi-
tion of any of the above-listed AHLs to the growth medium did
not positively or negatively affect lacZ transcription (Fig. 3A and
data not shown).
It is possible that AHLs do not affect MalR or transcription











   










































   








   






























FIG 2 Effect of antibiotics on growth (open circles) and activation of a chro-
mosomal malA-lacZ reporter (solid circles). The data are from the B. thailan-
densis malA-lacZ reporter BT01447 grown 24 h with antibiotics as indicated.
The final growth yield is a percentage of that without added antibiotic mea-
sured as the OD600. -Galactosidase activity is reported as relative light units
normalized to the OD600.
malA R 
GACTGTAAGAAGTTGCAGTA 
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FIG 3 Expression of malA requires MalR and an intact lux box-like sequence
in recombinant E. coli. (A) Activation of the malA promoter in E. coli contain-
ing an arabinose-inducible malR expression vector (pJN105.malR) and a lacZ
reporter with either the wild-type malA promoter (pQF50.PmalA) (circles)
or the malA promoter with the T4C and G5A base substitutions
(pQF50.mutPmalA) (triangles). The values are the means 	 ranges of the
results of two independent experiments. Asterisks, E. coli containing
pJN105.malR and pQF50.PmalA grown with 0.4 or 0.004% arabinose and 5
M (each) C8-HSL, 3OHC8-HSL, and 3OHC10-HSL (the B. thailandensis
AHLs). Similar results were obtained with 5 M C4-, C6-, C10-, C12-, C14-,
3OHC6-, and p-coumaroyl-HSL. (B) malR-malA B. thailandensis genomic re-
gion. The putative lux box-like element is centered 63.5 bp upstream of the
malA translation start site. The red letters indicate the T4C and G5A base
substitutions in pQF50.PmalA. (C) Alignment of the malA lux box-like se-
quence with the lux boxes from Vibrio fischeri luxI, P. aeruginosa rhlI, and B.
mallei bmaI1.
An AHL-Independent LuxR Homolog
November 2015 Volume 197 Number 21 jb.asm.org 3459Journal of Bacteriology
from the malA promoter in recombinant E. coli but that they do
have an influence on malA expression in B. thailandensis. To test
this possibility, we measured lacZ expression from the malA-lacZ
reporter in the parent B. thailandensis strain, a malR mutant, and
a mutant incapable of producing any AHLs. Cells were grown
both with and without added AHLs (Fig. 4). As previously shown
(Fig. 1), trimethoprim induced lacZ expression in the malR wild
type but not in the malR mutant. Trimethoprim also induced
malA-lacZ activity in the AHL synthesis mutant (Fig. 4). In the
absence of trimethoprim, self-produced or exogenously added
AHLs modestly repressed malA-lacZ reporter activity by about
2-fold (Fig. 4). Because malR is not expressed under these condi-
tions (11), we posit that this may be due to cross-regulation by one
of the other LuxR homologs encoded in the B. thailandensis chro-
mosome. Our results with both recombinant E. coli and B. thai-
landensis are consistent with our conclusion that trimethoprim
activates malA-lacZ expression in a MalR-dependent fashion and
show that the AHLs we tested, including the B. thailandensis
AHLs, are not required for MalR-mediated activation of the mal
operon.
MalR-dependent activation of malA transcription correlates
with malR transcription. Our results with recombinant E. coli
(Fig. 3) suggest the possibility that MalR does not require a ligand
to activate mal gene expression. It may be that a sufficient level of
MalR is the only requirement for activation of mal gene expression
and that trimethoprim and certain other antibiotics somehow ac-
tivate malR transcription. In fact, trimethoprim, piperacillin, and
malleilactone all induce malR expression in B. thailandensis (11)
(see Fig. S1 in the supplemental material). Furthermore, we con-
structed a strain with plac-malR in a neutral site (glmS1) on the
chromosome of a B. thailandensis malR mutant containing the
malA-lacZ reporter. We monitored malA expression in this strain,
grown with or without trimethoprim and increasing concentra-
tions of IPTG to induce plac-malR expression. We found that
activation of malA-lacZ required IPTG but not trimethoprim
(Fig. 5).
Although trimethoprim was not required for malA-lacZ acti-
vation, it had a modest stimulatory influence on IPTG-dependent
activation of malA-lacZ. This raised the possibility that trim-
ethoprim does interact with MalR directly to affect its ability to
activate mal gene expression. We addressed the possibility that
trimethoprim is a ligand for MalR by introducing a gene coding
for a trimethoprim-resistant dihydrofolate reductase (dhfrIIb)
into our reporter strain. We found that dhfrIIb completely abol-
ished trimethoprim-dependent activation of malA-lacZ (Fig. 5).
Because the dhfrIIB product changes the target of trimethoprim
and does not affect trimethoprim itself, we conclude that although
trimethoprim activation of the mal operon is MalR dependent,
the trimethoprim effect does not result from a direct interaction of
trimethoprim and MalR. This is consistent with the hypothesis
that trimethoprim serves to activate malR transcription and that
elevated levels of MalR are sufficient to activate the otherwise si-
lent mal genes in laboratory cultures of B. thailandensis.
DISCUSSION
Here, we describe an unusual LuxR family protein, MalR, which
retains all of the conserved amino acid residues in the AHL bind-
ing domains of LuxR family members involved in AHL quorum
sensing but does not require an AHL for activity. Generally, LuxR
family members that do not respond to AHLs have one or more
substitutions in the conserved residues of the AHL binding do-
main. For example, X. oryzae OryR responds to a plant-derived
signal (9), P. asymbiotica PauR responds to dialkylresorcinols (9,
10), and Serratia sp. CarR appears to be like MalR in that it does
not seem to require an AHL or any exogenously added ligand for
activity (23). CarR activity may also correspond to its level of
transcription (24, 25). Although CarR has a change in one of the
conserved AHL binding residues, genetic evidence supports the
idea that the conversion to AHL independence occurred through
mutations in the C terminus (23). The C-terminal mutations in
CarR (23) are in a region that is not present in MalR.
The B. thailandensis mal gene cluster is silent in laboratory-
grown cultures, but mal gene expression can be activated by cer-
tain antibiotics. We have shown that antibiotic activation of the
mal genes requires MalR. Our results also indicate that antibiotics
activate mal gene expression indirectly by driving malR expres-



















FIG 4 Transcriptional activation of a malA-lacZ chromosomal fusion in B.
thailandensis. Growth-adjusted -galactosidase activity is shown as a percent-
age of wild-type control values. The open bars indicate activity in the absence
of trimethoprim, and the solid bars indicate activity in the presence of 15
g/ml trimethoprim. Parent, B. thailandensis with the malA-lacZ chromo-
somal reporter (BT01447); MalR, BT01447 with a malR deletion (TT04);
AHL, BT01447 with deletions of all three of the AHL synthase genes
(
btaI1-3) (TT10); AHLs, 5 M (each) C8-HSL, 3OHC8-HSL, and 3OHC10-
HSL; TpR, BT01447 with the dhfrII gene conferring trimethoprim resistance
inserted in the neutral chromosomal attn7 site (TT05). The values are the
means and ranges of the results from two independent experiments. Statistical
analysis was done with a t test compared to the untreated parent; *, P  0.05.


















FIG 5 IPTG-dependent activation of malA-lacZ by a lac promoter-controlled
malR in B. thailandensis. Cells were grown with 15 g/ml trimethoprim (solid
symbols) or without trimethoprim (open symbols) and IPTG as indicated.
Shown is the growth-adjusted activity of a malA-lacZ chromosomal reporter in
the native malR deletion with a lac promoter-controlled malR strain (TT08)
(circles) and an isogenic strain with the lac promoter but no malR (TT07)
(squares). The values are the means 	 ranges from the results of two indepen-
dent experiments. Statistical analysis was done by t test of the trimethoprim-
treated strain compared to the identical strain grown without trimethoprim; *,
P  0.05.
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sion. This conclusion is based on our results with B. thailandensis
(Fig. 1 and 4) and a B. thailandensis AHL signal synthesis mutant
and a trimethoprim-resistant mutant (Fig. 4), as well as with E. coli
(Fig. 3), showing that sufficient levels of malR expression are all
that is needed to activate mal gene expression. In our experiments,
MalR does not appear to require an AHL or a ligand added to the
culture medium to influence mal gene expression. It is possible
that a common metabolite in B. thailandensis and E. coli serves as
a ligand. Recently, the E. coli LuxR orphan SdiA was shown to bind
a conserved metabolite (1-octanoyl-rac-glycerol) in the absence of
its cognate AHL (13). SdiA has some activity in the absence of
AHLs, as do a few other AHL-responsive LuxR homologs (e.g.,
Burkholderia cenocepacia CepR2) (26, 27). It is not known if any
other LuxR proteins bind common metabolites, like SdiA. In ways
other than the AHL requirement, MalR is similar to LuxR quo-
rum-sensing signal receptors. For example, MalR requires an in-
tact lux box-like sequence to activate the promoter of the mallei-
lactone-biosynthetic genes.
Transcription of malR is activated by several, but not all, of the
antibiotics we tested. In every case, antibiotics that activated mal
gene expression also slowed the growth of B. thailandensis, with
growth and mal activation inversely correlated. However, the in-
fluence of an antibiotic on growth was not in itself sufficient for
mal gene activation. Some antibiotics slowed growth but did not
affect mal gene activation. We imagine that the presence of certain
antibiotics activates a specific cellular response pathway, which in
turn activates expression of malR. Malleilactone may activate the
mal genes through a similar pathway, although the cellular target
of malleilactone is unknown. We find it interesting that antibiotic
modulation of AHL-responsive LuxR family members has been
reported elsewhere (28, 29). In fact, several classes of antibiotics
activate transcription of the P. aeruginosa orphan QscR (29).
MalR might be a degenerate AHL quorum-sensing signal recep-
tor. There is increasing evidence that AHL receptors play an im-
portant role in interspecies competition (30, 31). Antibiotics and
cytotoxic factors are often activated by AHL quorum sensing (31–
33), and as discussed above, MalR (11) and QscR (29) are antibi-
otic activated. The mal genes code for synthesis of malleilactone,
which is a cytotoxin that also has antibiotic activity against several
Gram-positive bacteria (12), and as we show here (Fig. 2), mallei-
lactone even slows the growth of B. thailandensis at high concen-
trations. Activation of the mal genes by low, nonlethal concentra-
tions of antibiotics might be an alarm response whereby B.
thailandensis reacts to danger by mounting an attack against com-
petitors.
B. thailandensis is closely related to two human pathogens,
Burkholderia pseudomallei and Burkholderia mallei. The malleilac-
tone-biosynthetic gene clusters are conserved (80% identity at
the amino acid sequence level), and MalR shows 100% identity
across these three species. B. pseudomallei is the causative agent of
melioidosis, an often fatal emerging infectious disease that is prev-
alent in northeast Thailand (34). One of the difficulties in treat-
ment is the high level of antibiotic resistance in B. pseudomallei.
Trimethoprim and sulfamethoxazole are two of the few clinically
useful antibiotics (35). Both of these antibiotics activate malleilac-
tone production in B. thailandensis (Table 1). These findings, to-
gether with the finding that malleilactone is important for B. thai-
landensis virulence in C. elegans (12), suggest the need to evaluate
how antibiotics regulate virulence and the gene homologs for mal-
leilactone and MalR in B. pseudomallei. Finally, it is interesting
that at sufficiently high concentrations (15 g/ml) malleilactone
itself inhibits the growth of B. thailandensis. Members of the genus
Burkholderia are quite insensitive to most antibiotics, and this
creates clinical difficulties (36). It is not unreasonable to think that
malleilactone might provide a scaffold for anti-Burkholderia
agents or that discovery of the malleilactone target might be help-
ful in drug discovery.
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